- Home
- TRAW vs DSS Comparison
TRAW vs DSS Comparison
Compare TRAW & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRAW
- DSS
- Stock Information
- Founded
- TRAW 1998
- DSS 1984
- Country
- TRAW United States
- DSS United States
- Employees
- TRAW N/A
- DSS N/A
- Industry
- TRAW
- DSS Containers/Packaging
- Sector
- TRAW
- DSS Consumer Discretionary
- Exchange
- TRAW NYSE
- DSS Nasdaq
- Market Cap
- TRAW 7.8M
- DSS 8.1M
- IPO Year
- TRAW 2013
- DSS N/A
- Fundamental
- Price
- TRAW $1.65
- DSS $0.85
- Analyst Decision
- TRAW
- DSS
- Analyst Count
- TRAW 0
- DSS 0
- Target Price
- TRAW N/A
- DSS N/A
- AVG Volume (30 Days)
- TRAW 3.5M
- DSS 13.6K
- Earning Date
- TRAW 05-15-2025
- DSS 05-15-2025
- Dividend Yield
- TRAW N/A
- DSS N/A
- EPS Growth
- TRAW N/A
- DSS N/A
- EPS
- TRAW N/A
- DSS N/A
- Revenue
- TRAW $227,000.00
- DSS $20,180,000.00
- Revenue This Year
- TRAW $3.81
- DSS N/A
- Revenue Next Year
- TRAW $30.43
- DSS N/A
- P/E Ratio
- TRAW N/A
- DSS N/A
- Revenue Growth
- TRAW 0.44
- DSS 12.88
- 52 Week Low
- TRAW $0.97
- DSS $0.72
- 52 Week High
- TRAW $19.44
- DSS $1.90
- Technical
- Relative Strength Index (RSI)
- TRAW 54.15
- DSS 43.41
- Support Level
- TRAW $1.30
- DSS $0.79
- Resistance Level
- TRAW $2.58
- DSS $0.89
- Average True Range (ATR)
- TRAW 0.23
- DSS 0.06
- MACD
- TRAW 0.07
- DSS -0.01
- Stochastic Oscillator
- TRAW 34.04
- DSS 63.77
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.